Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
This study compared serum antibody titers and granzyme B (GrzB) levels in virus-stimulated peripheral blood mononuclear cells following influenza vaccination. Twelve of 239 older adults who subsequently developed laboratory-diagnosed influenza illness (LDI) had significantly lower GrzB levels compared to subjects without LDI (P=0.004). Eight subjects with LDI in the previous year showed an enhanced GrzB response to vaccination (P=0.02). Serum antibody titers following vaccination did not distinguish those older adults who developed LDI from those who did not. These results suggest that GrzB levels could be combined with antibody titers to more effectively predict vaccine efficacy in older adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213 · cited 1×
“Rising hospitalization and death rates have been observed despite widespread influenza vaccination programs [1,2].”
BackgroundSaurwein-Teissl, M., Lung, T. L., Marx, F., Gschösser, C., Asch, E., Blasko, I., Parson, W., Böck, G., Schönitzer, D., Trannoy, E., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5893 · Cited by 499
Goronzy, J. J., Fulbright, J. W., Crowson, C. S., Poland, G. A., O'Fallon, W. M., & Weyand, C. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12182-12187.2001 · Cited by 402 · cited 1×
“Poor vaccine-mediated protection in older adults has been attributed to age-related defects in cellular immune function based on polyclonal stimulation, which correlate with protective versus non-protective levels of influenza-specific antibody titers [29,30].”
BackgroundRole of T lymphocyte replicative senescence in vaccine efficacy
Effros, R. B. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.08.032 · Cited by 152 · cited 2×
“Further studies combining measures of both humoral and cellular immune responses could shed light on how each of these responding lymphocyte subsets may contribute to cytolytic mechanisms of protection against influenza, and to cytokine-mediated cellular immune responses to influenza vaccination with aging [3,12,31].”
Background
Cited by
SARS-CoV-2 vaccines in development
Krammer, F. (2020) · Nature · doi:10.1038/s41586-020-2798-3 · Cited by 2,098
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
Immunosenescence: Implications for response to infection and vaccination in older people
Pera, A., Campos, C., López, N., Hassouneh, F., Alonso, C., Tarazona, R., & Solana, R. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.05.004 · Cited by 373
Immunosenescence: what does it mean to health outcomes in older adults?
McElhaney, J. E., & Effros, R. B. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.023 · Cited by 340
Self-citationInfluenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection
Ohmit, S. E., Petrie, J. G., Cross, R. T., Johnson, E., & Monto, A. S. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir661 · Cited by 296
Metadata
- Authors
- McElhaney, J. E., Ewen, C., Zhou, X., Kane, K. P., Xie, D., Hager, W. D., Barry, M. B., Kleppinger, A., Wang, Y., & Bleackley, R. C.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 27
- Issue
- 18
- Pages
- 2418-2425
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2026625581
- Cited by
- 218
- References
- 5
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. https://app.cochat.ai/papers/10.1016/j.vaccine.2009.01.136
- The paper
- McElhaney, J. E., Ewen, C., Zhou, X., Kane, K. P., Xie, D., Hager, W. D., Barry, M. B., Kleppinger, A., Wang, Y., & Bleackley, R. C. (2009). Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine. https://doi.org/10.1016/j.vaccine.2009.01.136
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.